AbbVie (ABBV) announced that the European Commission granted marketing authorization to Rinvoq for the treatment of giant cell arteritis in adult patients. Rinvoq is the first and only oral JAK ...

AbbVie. "This exciting milestone demonstrates our commitment to ongoing research and expanding indications in areas of high unmet need to help patients achieve better outcomes, including sustained ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on AbbVie (ABBV – Research Report) today and set a price target of $239.00. The company’s shares closed last Friday at $186.96.

Well, scientists have already proven it can be done. And now they’ve developed a new kind of transparent wood that acts like glass but with surprising advantages. Not only is it strong and ...

The logo itself has stirred up big talk ... Menus, keyboards, buttons, everything might now shimmer with that semi-transparent, depth-rich look inspired by Vision Pro. The goal? A more immersive, ...